Eansor Norman David has filed 3 insider transactions across 1 company since February 2025.
Most recent transaction: a grant/award of 84411 shares of Marker Therapeutics, Inc. ($MRKR) on November 17, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 17, 2025 | Marker Therapeutics, Inc. | $MRKR | Eansor Norman David | Director | A | Stock Option (Right to Buy) | 84411 | $0.00 | 84,411.0000 | 16,757,678 | 9999.99% | 0.50% |
| Nov. 17, 2025 | Marker Therapeutics, Inc. | $MRKR | Eansor Norman David | Director | A | Stock Option (Right to Buy) | 137330 | $0.00 | 137,330.0000 | 16,757,678 | 9999.99% | 0.82% |
| Feb. 12, 2025 | Marker Therapeutics, Inc. | $MRKR | Eansor Norman David | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 8,980,207 | 9999.99% | 0.33% |